pramipexole has been researched along with Abnormal Movements in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Artusi, CA; Bozzali, M; Covolo, A; Imbalzano, G; Ledda, C; Lopiano, L; Martone, T; Montanaro, E; Rizzone, MG; Romagnolo, A; Zibetti, M | 1 |
| Chen, F; Chen, X; Wen, S; Zhang, Q; Zhou, C | 1 |
| Hattori, N | 1 |
| Jackson, MJ; Jenner, P; Olanow, CW; Rose, S; Tayarani-Binazir, KA | 1 |
| Albrecht, S; Barone, P; Debieuvre, C; Massey, D; Poewe, W; Rascol, O; Tolosa, E; Weintraub, D | 1 |
| Fernandez, HH; Merello, M | 1 |
| Montgomery, EB | 1 |
| Hauser, RA; McDermott, MP; Messing, S | 1 |
3 review(s) available for pramipexole and Abnormal Movements
| Article | Year |
|---|---|
Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Levodopa; Network Meta-Analysis; Parkinson Disease; Pergolide; Pramipexole | 2023 |
[Programs for continuing medical education: a session: 4. The pathogenesis and update for the treatments of Parkinson's disease].
Topics: Benserazide; Benzothiazoles; Catechols; Circadian Rhythm; Dementia; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Dyskinesias; Education, Medical, Continuing; Hallucinations; Humans; Levodopa; Nitriles; Parkinson Disease; Practice Guidelines as Topic; Pramipexole; Reference Standards; Referral and Consultation | 2014 |
Two advances in the management of Parkinson disease.
Topics: Age Factors; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dyskinesias; Electric Stimulation Therapy; Forecasting; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Risk Factors; Stereotaxic Techniques; Thiazoles | 2002 |
3 trial(s) available for pramipexole and Abnormal Movements
| Article | Year |
|---|---|
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Topics: Aged; Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Depressive Disorder; Dopamine Agonists; Double-Blind Method; Dyskinesias; Europe; Female; Humans; Male; Parkinson Disease; Pramipexole; Psychiatric Status Rating Scales; Severity of Illness Index; South Africa; Time Factors; Treatment Outcome | 2010 |
Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.
Topics: Age of Onset; Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Dyskinesias; Female; Humans; Levodopa; Logistic Models; Male; Middle Aged; Parkinson Disease; Pramipexole; Proportional Hazards Models; Prospective Studies; Retrospective Studies | 2006 |
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
Topics: Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Dyskinesias; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Proportional Hazards Models; Quality of Life; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2000 |
3 other study(ies) available for pramipexole and Abnormal Movements
| Article | Year |
|---|---|
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson's disease patient with Parkin gene mutation: a case report.
Topics: Adult; Deep Brain Stimulation; Dyskinesias; Humans; Levodopa; Male; Mutation; Parkinson Disease; Pramipexole; Quality of Life; Subthalamic Nucleus; Treatment Outcome | 2023 |
Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Callithrix; Carbidopa; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesias; Levodopa; Male; Motor Activity; MPTP Poisoning; Pramipexole; Time Factors | 2010 |
Pramipexole for depression and motor symptoms in Parkinson's disease: can we kill two birds with one stone?
Topics: Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Depressive Disorder; Dopamine Agonists; Dyskinesias; Humans; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic | 2010 |